Search results
Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) reports encouraging third-quarter 2022 results. The narrower-than-expected loss is on...
Nektar Therapeutics (NKTR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings...
Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) delivered earnings and revenue surprises of 48.94% and 1.35%, respectively, for the...
Here's Why We're Watching Nektar Therapeutics' (NASDAQ:NKTR) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 19, 2023 – Stocks in this week’s article are Disney DIS,...
RA Capital Management, L.P. Acquires Significant Stake in Nektar Therapeutics
GuruFocus.com via Yahoo Finance· 10 months agoRA Capital Management, L.P., a Boston-based investment firm, recently made a significant acquisition...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks via Yahoo Finance· 2 years agoLaunched on 06/19/2006, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange...
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Zacks via Yahoo Finance· 2 years agoMaking its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH)...